Catheter-directed therapy to treat intermediateand high-risk pulmonary embolism: Personal experience and review of the literature
- PMID: 35975795
- PMCID: PMC10287075
- DOI: 10.5603/CJ.a2022.0075
Catheter-directed therapy to treat intermediateand high-risk pulmonary embolism: Personal experience and review of the literature
Abstract
Pulmonary embolism (PE) is the third leading cause of cardiovascular death in the western world. Prompt recognition, risk stratification, and individualized treatment are crucial to improve outcomes in patients with PE. Anticoagulation alone is a sufficient therapeutic option in low-risk patients, whereas primary reperfusion with systemic thrombolysis (ST) is usually chosen in high-risk patients. The choice of treatment in intermediate-risk patients is complex and depends on the clinical presentation. Catheter-directed therapy (CDTh) includes all therapies delivered via a catheter placed in the branches of the pulmonary arteries directly into the thrombus. Because ST bears a high risk of major bleeding and numerous patients have contraindications to ST, CDTh is an alternative to ST in intermediate- and high-risk PE patients. CDTh includes local thrombolysis using low-dose alteplase, ultrasound-assisted thrombolysis, and mechanical fragmentation and aspiration of the thrombi, as well as their combinations. In this review article, we have summarized devices and technical details for CDTh, discussed the efficacy and safety of CDTh in comparison to ST in previous clinical trials, and outlined future research directions regarding CDTh, both based on the literature and our personal experience from the local PE Response Team of the Center for the Management of Pulmonary Embolism (CELZAT) in Warsaw.
Keywords: catheter-based therapy; interventional cardiology; pulmonary embolism; review.
Conflict of interest statement
Figures


Similar articles
-
Systemic thrombolytic and ultrasound-assisted catheter-directed thrombolysis for treatment of acute pulmonary embolism: a 7-year, multicenter experience.J Thromb Thrombolysis. 2023 Apr;55(3):545-552. doi: 10.1007/s11239-022-02760-z. Epub 2022 Dec 30. J Thromb Thrombolysis. 2023. PMID: 36585600
-
Interventional Treatment of Pulmonary Embolism.Circ Cardiovasc Interv. 2017 Feb;10(2):e004345. doi: 10.1161/CIRCINTERVENTIONS.116.004345. Circ Cardiovasc Interv. 2017. PMID: 28213377 Review.
-
Interventional therapies for pulmonary embolism.Nat Rev Cardiol. 2023 Oct;20(10):670-684. doi: 10.1038/s41569-023-00876-0. Epub 2023 May 12. Nat Rev Cardiol. 2023. PMID: 37173409 Free PMC article. Review.
-
Ultrasound-Assisted Catheter-Directed Thrombolysis for the Management of Pulmonary Embolism: A Single Center Experience in a Community Hospital.J Cardiovasc Pharmacol Ther. 2024 Jan-Dec;29:10742484241238656. doi: 10.1177/10742484241238656. J Cardiovasc Pharmacol Ther. 2024. PMID: 38483845
-
Catheter-directed thrombolysis versus suction thrombectomy in the management of acute pulmonary embolism.J Vasc Surg Venous Lymphat Disord. 2019 Sep;7(5):623-628. doi: 10.1016/j.jvsv.2018.10.025. Epub 2019 Mar 20. J Vasc Surg Venous Lymphat Disord. 2019. PMID: 30902560
Cited by
-
Treatment of high- and intermediate-high-risk pulmonary embolism by the Pulmonary Embolism Response Team: Focus on catheter-directed therapies.Cardiol J. 2024;31(2):215-225. doi: 10.5603/CJ.a2023.0047. Epub 2023 Jul 31. Cardiol J. 2024. PMID: 37519055 Free PMC article.
-
Predictors of Residual Pulmonary Vascular Obstruction after Acute Pulmonary Embolism Based on Patient Variables and Treatment Modality.J Clin Med. 2024 Jul 20;13(14):4248. doi: 10.3390/jcm13144248. J Clin Med. 2024. PMID: 39064289 Free PMC article.
-
Initial results of investigator initiated international database on catheter directed therapy of acute pulmonary embolism.Cardiol J. 2024;31(3):390-397. doi: 10.5603/cj.95949. Epub 2023 Sep 29. Cardiol J. 2024. PMID: 37772352 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical